Mandatory biosimilar switching pays off for Canada
For Alberta and Green Shield Canada savings are beginning to add up from switching initiatives for multiple reference biologics, reports the American Journal of Managed Care (AJMC).
Biosimilars Canada has compiled a list of news stories from Canada and abroad about biosimilars that may be of interest to readers. These links to third-party websites are provided for informational purposes only, and do represent an endorsement from our organization. Biosimilars Canada’s statements and news releases are available here.
For Alberta and Green Shield Canada savings are beginning to add up from switching initiatives for multiple reference biologics, reports the American Journal of Managed Care (AJMC).
CBC News report on the announcement of the province’s biosimilars initiative.
Following the lead of British Columbia and Alberta, New Brunswick hopes to save on biologics, reports The Center for Biosimilars.
Coverage by The Center for Biosimilars of the adalimumab phase of the BC’s biosimilars program.
Alan Birch, RPhT provides a drug access navigator’s point of view in this Biosimilars in Oncology - Winter 2021 article. Posted with permission of Catalytic Health.
Assistant Professor Kathy Vu, BSc (Pharm), PharmD highlights biosimilar education initiatives undertaken by the Leslie Dan Faculty of Pharmacy at the University of Toronto in this Biosimilars in Oncology - Winter 2021 article. Posted with permission of Catalytic Health.